Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study
Abstract Background Children are particularly at risk of malaria. This analysis consolidates the clinical data for pyronaridine–artesunate (PA) paediatric granules in children from three randomized clinical trials and a real-world study (CANTAM). Methods An integrated safety analysis of individual p...
Main Authors: | Michael Ramharter, Abdoulaye A. Djimde, Isabelle Borghini-Fuhrer, Robert Miller, Jangsik Shin, Adam Aspinall, Naomi Richardson, Martina Wibberg, Lawrence Fleckenstein, Sarah Arbe-Barnes, Stephan Duparc |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-024-04885-3 |
Similar Items
-
Therapeutic efficacy of pyronaridine-artesunate (Pyramax®) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia
by: Mihreteab Alebachew, et al.
Published: (2023-06-01) -
Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01) -
Review of pyronaridine anti-malarial properties and product characteristics
by: Croft Simon L, et al.
Published: (2012-08-01) -
Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia
by: Hussein Mohammed, et al.
Published: (2022-12-01) -
<it>Ex vivo </it>activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of <it>Plasmodium falciparum</it>
by: Pascual Aurélie, et al.
Published: (2012-02-01)